Correction to: Cell Research (2015) 25:1175–1178. doi:10.1038/cr.2015.101; published online 28 August 2015
The authors apologized for the mistake of mis-labeling the affiliation for Drs Xiaoming Dai, Huan Liu, Shuying Shen, Xiaocan Guo, Huan Yan, Xinyan Ji, Jun Huang, Xin-Hua Feng, Bin Zhao. The correct form is as follows.
We apologize for any inconvenience that may have been caused by our error.
Xiaoming Dai1, *, Huan Liu1, *, Shuying Shen1, 2, Xiaocan Guo1, Huan Yan1, Xinyan Ji1, Li Li3, Jun Huang1, Xin-Hua Feng1, Bin Zhao1
1Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang 310058, China; 2Institute of Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China; 3Institute of Aging Research, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China
*These two authors contributed equally to this work.
Author information
Authors and Affiliations
Additional information
The online version of the original article can be found at 10.1038/cr.2015.101
Rights and permissions
About this article
Cite this article
Dai, X., Liu, H., Shen, S. et al. Erratum: YAP activates the Hippo pathway in a negative feedback loop. Cell Res 27, 1073 (2017). https://doi.org/10.1038/cr.2017.96
Published:
Issue Date:
DOI: https://doi.org/10.1038/cr.2017.96
This article is cited by
-
The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis
Oncogene (2024)
-
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer
Nature Communications (2022)
-
CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway
Journal of Translational Medicine (2021)
